2268.HK
WuXi XDC Cayman Inc
1W: +1.6%
1M: -11.5%
3M: -15.3%
YTD: -12.0%
1Y: +86.2%
HK$56.15 ($7.18)
-0.95 (-1.66%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market CapHK$71.8B ($9.2B)
52W Range24.7-85.5
Volume4,331,693
Avg Volume4,219,705
Beta-2.10
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJincai Li
Employees2,041
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2012-06-18
Websitewuxixdc.com
No. 11 Xinhui Ring Road
Wuxi
CN
Wuxi
CN
About WuXi XDC Cayman Inc
WuXi XDC Cayman Inc., an investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally. It engages in the discovery, research, development, and manufacture of antibody drug conjugates, bioconjugates, monoclonal antibody intermediates, and payload-linkers associated with bioconjugates. The company was founded in 2013 and is headquartered in Wuxi, China. WuXi XDC Cayman Inc. operates as a subsidiary of WuXi Biologics (Cayman) Inc.
Recent Insider Trades
No insider trades found